news
Scientists jump hurdle in HIV vaccine design
Scientists at The Scripps Research Institute (TSRI) have made another important advance in HIV vaccine design.
List view / Grid view
HIV
news
Novel antibacterial wound cover made from crustaceans
Researchers develop bacteria-fighting wound dressing made with the help of crustaceans…
news
Kymab receives $9m R+D grant from Bill & Melinda Gates Foundation
The monoclonal antibody biopharmaceutical group Kymab announced today that it has received a $9m grant from the Bill & Melinda Gates Foundation to accelerate the development of novel vaccines and therapeutics for infectious diseases, including HIV.
news
HIV test performed on USB stick
10 November 2016 | By Niamh Louise Marriott, Digital Content Producer
The technology could enable patients with HIV to be managed more effectively in remote locations and can produce a result in under 30 minutes...
news
New biologic drug benefits patients with multi-drug resistant HIV
31 October 2016 | By Niamh Louise Marriott, Digital Content Producer
A new biologic medication - the first for HIV - is showing promise in treating patients with multidrug resistance, according to phase 3 research...
news
Toys and ‘enriched’ surroundings help fight infection in mice
30 September 2016 | By Niamh Louise Marriott, Digital Content Producer
A simple set of alterations to a mouse’s living space, adding toys, caused dramatic changes to their T cells, making them a more protective inflammatory...
news
Discovery of how HIV virus spreads leads to new drug target
11 August 2016 | By Medical Research Council (MRC) Laboratory of Molecular Biology
HIV is surrounded by a protein shell called the capsid. It has now been found that HIV hides within the capsid while it builds DNA...
article
How NIH’s $30 million research fund will help find HIV cure
20 July 2016 | By Niamh Louise Marriott, Digital Content Producer
The NIH recently awarded $30 million to advance science towards a cure for HIV. Drug Target Review caught up with the Wistar Institute‘s Dr. Luis Montaner, co-leader of the BEAT-HIV project...
news
NIH funds six research collaborations to find a cure for HIV
14 July 2016 | By Victoria White, Digital Content Producer
The US National Institutes of Health has awarded $30 million in annual funding to help advance science towards a cure for HIV...
news
Small doses of anti-HIV drug efavirenz might treat Alzheimer’s
29 June 2016 | By Victoria White, Digital Content Producer
A study suggests efavirenz might be an effective therapy for stimulating cholesterol turnover from the brain and slowing or preventing Alzheimer's disease...
news
Scientists stabilise HIV structure and design potential vaccine candidates
29 June 2016 | By Victoria White, Digital Content Producer
Scientists have described a strategy to stabilise an important HIV structure and potentially create HIV lookalikes for large-scale vaccine production...
news
HIV vaccine candidate confirms promise in preclinical study
11 April 2016 | By Victoria White, Digital Content Producer
Mymetics’ HIV vaccine candidate generated significant protection in groups of twelve female monkeys against repeated AIDS virus exposures...
news
First glimpse of an immature HIV-neutralising antibody
6 April 2016 | By Victoria White
Scientists have described the first-ever immature antibody found in a powerful class of immune molecules effective against HIV. TSRI biologist Jiang Zhu called the antibody a “teenager” and said it gives scientists a unique view of the steps needed to prompt the immune system to effectively target HIV...
news
New study looks at why pharma may prefer to invest in drugs over vaccines
3 March 2016 | By Victoria White
According to the research, a drug for a disease that affects twice as many people will generate twice the revenue. But vaccine revenue depends on finer details about how the risk is distributed in the population...
news
Gilead announces preclinical results for TLR7 agonist GS-9620
25 February 2016 | By Victoria White
Data from the preclinical study support continued investigation of GS-9620 as part of an HIV eradication strategy…
